This review summarizes the rationale, design, strengths, and limitations of questionnaires used to assess quality of life in atrial fibrillation and presents outcomes from major intervention studies.
How is quality of life measured and impacted by interventions in patients with atrial fibrillation?
This review highlights the importance of quality of life as a treatment goal in atrial fibrillation and summarizes the tools used to measure it and the interventions that improve it.
Quality of life (QoL) is of central importance in atrial fibrillation as both a treatment goal and an endpoint in the evaluation of new therapies. QoL appears to be impaired in the majority of patients with AF. A number of interventions for AF have been shown to improve QoL, including pharmacologic and nonpharmacologic rate control, antiarrhythmic drugs, and nonpharmacologic rhythm control strategies. This paper will review the rationale, design, strengths, and limitations of the questionnaires most commonly used to assess QoL in AF studies, and present QoL outcomes from major studies of AF interventions.
Reynolds et al. (Wed,) conducted a review in Atrial Fibrillation. AF interventions (rate control, antiarrhythmic drugs, rhythm control) was evaluated on Quality of life. This review summarizes the rationale, design, strengths, and limitations of questionnaires used to assess quality of life in atrial fibrillation and presents outcomes from major intervention studies.